Related Experiment Video
Updated: Feb 10, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[MicroRNA in ischemic stroke]
K A Aitbaev1, I T Murkamilov2, V V Fomin3
1Scientific and Research Institute of Molecular biology and medicine, Bishkek, Kyrgyzstan.
Abstract:
Today, stroke is the third most common pathology after cardiovascular disease and cancer, as well as the leading cause of disability in the world. Although some progress has been made in the field of primary and secondary stroke prevention over the past few decades, a deeper knowledge of the pathophysiology of the disease is needed to significantly improve diagnosis and therapy. MicroRNA (miRNA) is an important, recently identified class of posttranscriptional regulators of gene expression. MiRNA can be used as a tool for therapeutic interventions. This review considers a role of miRNAs in the regulation of experimental stroke and in the development of carotid artery stroke. A potential role of miRNAs as promising biomarkers of stroke is discussed.
Insights
MicroRNAs (miRNAs) are key gene regulators offering potential for stroke diagnosis and therapy. Understanding their role in stroke pathophysiology is crucial for improving patient outcomes and developing new treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Stroke is a leading cause of disability worldwide, necessitating improved diagnostic and therapeutic strategies.
- Current understanding of stroke pathophysiology requires advancement for better patient outcomes.
- MicroRNAs (miRNAs) represent a novel class of gene regulators with therapeutic and diagnostic potential.
Purpose of the Study:
- To review the role of miRNAs in experimental stroke models.
- To explore the involvement of miRNAs in carotid artery stroke development.
- To discuss the potential of miRNAs as biomarkers for stroke.
Main Methods:
- Literature review of studies on miRNA regulation in stroke.
- Analysis of experimental stroke models and carotid artery stroke development.
- Evaluation of miRNA as potential stroke biomarkers.
Main Results:
- MiRNAs play a significant role in regulating gene expression relevant to stroke.
- Specific miRNAs are implicated in the pathophysiology of experimental and carotid artery stroke.
- MiRNAs show promise as sensitive and specific biomarkers for stroke detection.
Conclusions:
- MicroRNAs are critical regulators in stroke pathophysiology.
- Targeting miRNAs offers a potential therapeutic avenue for stroke.
- MiRNAs hold significant promise as biomarkers for improved stroke diagnosis and management.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...

